2Seventy Bio Inc banner

2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 5 USD Market Closed
Market Cap: $266.2m

Wall Street
Price Targets

TSVT Price Targets Summary
2Seventy Bio Inc

There are no price targets for TSVT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
2Seventy Bio Inc Competitors:
Price Targets
FULT
Fulton Financial Corp
16% Upside
TCPC
BlackRock TCP Capital Corp
23% Upside
UFPT
UFP Technologies Inc
72% Upside
ESQ
Esquire Financial Holdings Inc
14% Upside

Revenue
Forecast

-3% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-3% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 5 years the compound annual growth rate for 2Seventy Bio Inc's revenue is -3%. The projected CAGR for the next 3 years is 29%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TSVT's stock price target?
Not Available

TSVT doesn't have any price targets made by Wall Street professionals.

What is 2Seventy Bio Inc's Revenue forecast?
Projected CAGR
29%

For the last 5 years the compound annual growth rate for 2Seventy Bio Inc's revenue is -3%. The projected CAGR for the next 3 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett